A composite endpoint for systemic sclerosis-associated interstitial lung disease: association with mortality in two clinical trial cohorts

By afschroeder • November 29, 2025

Volkmann ER, Wilhalme H, Good S, Kim GHJ, Goldin J, Roth MD, Tashkin DP. A composite endpoint for systemic sclerosis-associated interstitial lung disease: association with mortality in two clinical trial cohorts. Respir Res. 2025 Nov 28;26(1):337. doi: 10.1186/s12931-025-03401-8. PMID: 41316297; PMCID: PMC12661867.

Tags: DOM STAT, General Internal Medicine, interstitial lung disease, Patient Outcome Assessment, Publications, Pulmonary, Critical Care & Sleep Medicine, Randomized Controlled Trial, Rheumatology, systemic sclerosis

Eosinophilic cholangitis as an indeterminate biliary mimic: A systematic review of outcomes

Stirrat T, Wilkey M, Ransibrahmanakul V, Singh L, Allen O, Kanth P, Rangnekar A, Redfield R. Eosinophilic cholangitis as an indeterminate biliary mimic: A systematic[...]

Real-world clinical outcomes of Trastuzumab Deruxtecan in HER2-expressing ovarian and endometrial Cancer

Silverstein J, Alomaja O, Chatram D, Hajiabbasi M, Shachar E, Tseng CH, Thaker S, Bardia A, Karlan B, Hendrickson AW, Konecny GE. Real-world clinical outcomes[...]

Beyond Glycemia: Entering the Era of Hard Outcomes for Continuous Glucose Monitoring

Alkabbani W, Cromer SJ, Patorno E. Beyond Glycemia: Entering the Era of Hard Outcomes for Continuous Glucose Monitoring. Diabetes Care. 2026 Sep 1;49(9):1554-1556. doi: 10.2337/dci26-0084.[...]